Marketing-authorisation holder
Chemo Iberica S.A.
8 medicines in 2 countries, as authorisation holder and marketer.
Medicines
Every medicine in the registers under its name, current ones first.
8 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| IVABRADINA CHEMO IBERICA 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG5,390 mg · Comprimido recubierto con película | Ivabradine | Spain | Authorised | 2017 |
| IVABRADINA CHEMO IBERICA 7,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG8,085 mg · Comprimido recubierto con película | Ivabradine | Spain | Authorised | 2017 |
| Ivabradine Chemo Ibérica 5 mg filmomhulde tablettenFilmomhulde tablet | Ivabradine | Netherlands | Authorised | 2018 |
| Ivabradine Chemo Ibérica 7,5 mg filmomhulde tablettenFilmomhulde tablet | Ivabradine | Netherlands | Authorised | 2018 |
| Zalmeber 40 mg/12,5 mg tablettenTablet | Hydrochlorothiazide, Telmisartan | Netherlands | Authorised | 2013 |
| Zalmeber 80 mg/12,5 mg tablettenTablet | Hydrochlorothiazide, Telmisartan | Netherlands | Authorised | 2013 |
| Zalmeber 80 mg/25 mg tablettenTablet | Hydrochlorothiazide, Telmisartan | Netherlands | Authorised | 2013 |
| DUTASTERIDA CHEMO IBERICA 0,5 MG CAPSULAS BLANDAS EFG0,5 mg · Cápsula blanda | Dutasteride | Spain | Withdrawn | 2016 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Netherlands | 5 | 5 | 0 | CompaniesAll medicines |
| Spain | 3 | 2 | 1 | CompaniesAll medicines |
Therapeutic areas
The ATC groups most of its medicines belong to, largest first.
- Agents acting on the renin–angiotensin systemCardiovascular system · ATC C09D
- Cardiac therapyCardiovascular system · ATC C01E
Top substances
The active substances in most of its medicines.
Names in the registers
How the registers spell it, normalised: legal forms, accents and capitals removed.
- chemo iberica
- chemo iberica s a
Sources and licences
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Report an error or request removalCorrections from the company itself are welcome.
At a glance
- Type
- Marketing-authorisation holder
- Medicines
- 8
- Countries
- 2
- Roles
- Authorisation holder and marketer